Here are examples of what you need: - The full name of the patient - The full names and credentials of the professionals handling the patient - The name, address, and type of facility where the injection was administered - The relevant information and indications related to the patient to justify medical necessity - The date and time of administration - Drug information (e.g., drug name, dosage, strength, route of administration, lot number, manufacturer, National Drug Code, etc.) - Relevant assessments that show the patient's osteoporosis, including the location and sizes of fractures (if any) - Provider's order ## **Billing requirements for J3111** Besides the documentation requirements above, please take note of or have the following: - 1 mg = 1 unit - Use the appropriate ICD diagnosis code for your patient - Also use CPT code 96372 since this is a subcutaneous injection - Use either of two modifiers: JW if there's unused medication in a vial (wastage), or JZ if there's no unused medication - Make sure to have prior authorization ## **Other similar codes** - **J3230** - Injection, chlorpromazine hcl, up to 50 mg - **J3240** - Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial - **J3241** - Injection, teprotumumab-trbw, 10 mg - **J3243** - Injection, tigecycline, 1 mg - **J3244** - Injection, tigecycline (accord), not therapeutically equivalent to J3243, 1 mg Frequently asked questions
TH, T- Helper Cells
Though further research is underway on the MTHFR gene, its been suggested that those with this gene mutation resulting in hyperhomocysteinemia may experience issues with: Inflammation Memory Immunity Migraines Depression Cognition Sleep By restoring some of the common vitamin/nutrient deficiencies seen in this condition, homocysteine levels may begin to decrease, resulting in an improvement in some of these symptoms
However, observed ions can vary with ionization mode, adduct formation, mobile phase, and instrument settings
